Webinar Drug Delivery Devices for Net Zero Emissions: A Pharma Supply Chain Collaboration
15. November 2021

As a sector, the pharmaceutical industry's carbon emissions are even greater than that of the automotive industry - in the region of 55% more emission intensive. Drug delivery devices and the primary and secondary packaging account for a proportion of the CO2 emissions of combination products based on their design. The urgency of action required for global GHG emissions reduction means that parenteral packaging suppliers cannot work in isolation if they are to reach these GHG reduction goals. The Alliance to Zero was established to directly address this issue, by adopting the principles of the circular economy to facilitate the transition of the pharma sector to net zero emissions by 2030. This webcast will introduce the ambition of the Alliance of Zero, explain the methodology and impact the association intends to have and how pharma suppliers can participate.

Register now

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Dätwyler Holding AG published this content on 15 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 16 November 2021 20:36:04 UTC.